Literature DB >> 16094002

Dietary oxalate loads and renal oxalate handling.

Ross P Holmes1, Walter T Ambrosius, Dean G Assimos.   

Abstract

PURPOSE: Dietary oxalate makes a significant contribution to urinary oxalate excretion and, thus, may have a role in calcium oxalate kidney stone formation. Studies have indicated that the ingestion of oxalate rich foods results in transient increases in plasma oxalate concentrations and urinary oxalate excretion. We examined changes in plasma and urinary oxalate following oral crystalline oxalate loading under controlled dietary conditions to further define the renal handling of oxalate by normal adults.
MATERIALS AND METHODS: Six normal adult subjects consumed controlled diets of known oxalate content for 1 week before ingesting loads of 0, 2, 4 and 8 mmol of oxalate. Urinary and plasma changes were measured to assess renal oxalate handling. Urinary excretion of proximal tubule derived enzymes and isoprostanes was monitored to assess for renal injury and oxidative stress.
RESULTS: Time and dose dependent changes in plasma oxalate, urinary oxalate and in the clearance ratio of oxalate-to-creatinine were observed. A significant correlation (r=0.43, p <0.001) between the oxalate-to-creatinine clearance ratio and plasma oxalate levels was identified. No changes in urinary markers of oxidative stress or renal injury were observed following the 8 mmol oxalate load.
CONCLUSIONS: Oxalate is rapidly absorbed and cleared by the kidney by filtration and secretion following an oral oxalate load. Renal oxalate secretion has a significant role in the renal handling of an oral oxalate load. There is no evidence of acute renal injury or oxidative stress with oral oxalate loads in these experimental conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16094002     DOI: 10.1097/01.ju.0000169476.85935.e2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  37 in total

1.  Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones.

Authors:  Kristin J Bergsland; Anna L Zisman; John R Asplin; Elaine M Worcester; Fredric L Coe
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-01

2.  Cholinergic signaling inhibits oxalate transport by human intestinal T84 cells.

Authors:  Hatim A Hassan; Ming Cheng; Peter S Aronson
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-28       Impact factor: 4.249

Review 3.  Intestinal adaptations in chronic kidney disease and the influence of gastric bypass surgery.

Authors:  Marguerite Hatch
Journal:  Exp Physiol       Date:  2014-06-20       Impact factor: 2.969

4.  Acute probiotic ingestion reduces gastrointestinal oxalate absorption in healthy subjects.

Authors:  Ismail Al-Wahsh; Yan Wu; Michael Liebman
Journal:  Urol Res       Date:  2011-08-28

5.  Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.

Authors:  Sushrut S Waikar; Anand Srivastava; Ragnar Palsson; Tariq Shafi; Chi-Yuan Hsu; Kumar Sharma; James P Lash; Jing Chen; Jiang He; John Lieske; Dawei Xie; Xiaoming Zhang; Harold I Feldman; Gary C Curhan
Journal:  JAMA Intern Med       Date:  2019-04-01       Impact factor: 21.873

6.  Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles.

Authors:  Takalani Theka; Allen Rodgers; Neil Ravenscroft; Sonja Lewandowski
Journal:  Urolithiasis       Date:  2013-01-22       Impact factor: 3.436

7.  Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers.

Authors:  John Knight; Juquan Jiang; Kyle D Wood; Ross P Holmes; Dean G Assimos
Journal:  Urology       Date:  2011-06-15       Impact factor: 2.649

Review 8.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

Review 9.  Interstitial calcinosis in renal papillae of genetically engineered mouse models: relation to Randall's plaques.

Authors:  Xue-Ru Wu
Journal:  Urolithiasis       Date:  2014-08-06       Impact factor: 3.436

Review 10.  Lowering urinary oxalate excretion to decrease calcium oxalate stone disease.

Authors:  Ross P Holmes; John Knight; Dean G Assimos
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.